Viridian Therapeutics, Inc.\DE (VRDN) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to -$34.6 million.
- Viridian Therapeutics, Inc.\DE's Profit After Tax rose 5488.4% to -$34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$302.0 million, marking a year-over-year decrease of 1746.01%. This contributed to the annual value of -$269.9 million for FY2024, which is 1355.09% down from last year.
- According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Profit After Tax is -$34.6 million, which was up 5488.4% from -$100.7 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Profit After Tax ranged from a high of -$14.0 million in Q3 2021 and a low of -$100.7 million during Q2 2025
- Moreover, its 5-year median value for Profit After Tax was -$47.7 million (2023), whereas its average is -$49.4 million.
- Examining YoY changes over the last 5 years, Viridian Therapeutics, Inc.\DE's Profit After Tax showed a top increase of 6810.08% in 2021 and a maximum decrease of 17916.08% in 2021.
- Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Profit After Tax stood at -$28.9 million in 2021, then plummeted by 58.17% to -$45.8 million in 2022, then crashed by 46.03% to -$66.9 million in 2023, then dropped by 19.24% to -$79.7 million in 2024, then skyrocketed by 56.6% to -$34.6 million in 2025.
- Its Profit After Tax stands at -$34.6 million for Q3 2025, versus -$100.7 million for Q2 2025 and -$86.9 million for Q1 2025.